Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan, L Gandhi… - Journal of Clinical …, 2016 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Alectinib has shown activity in the CNS
in phase I and II studies. To further evaluate this activity, we pooled efficacy and safety data …
in phase I and II studies. To further evaluate this activity, we pooled efficacy and safety data …
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - europepmc.org
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
[PDF][PDF] Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan, L Gandhi… - J Clin …, 2016 - clf1.medpagetoday.com
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - profiles.wustl.edu
Purpose: Alectinib has shown activity in the CNS in phase I and II studies. To further
evaluate this activity, we pooled efficacy and safety data from two single-arm phase II studies …
evaluate this activity, we pooled efficacy and safety data from two single-arm phase II studies …
[PDF][PDF] Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan, L Gandhi… - J Clin …, 2016 - researchgate.net
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - s-space.snu.ac.kr
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - snucm.elsevierpure.com
Purpose: Alectinib has shown activity in the CNS in phase I and II studies. To further
evaluate this activity, we pooled efficacy and safety data from two single-arm phase II studies …
evaluate this activity, we pooled efficacy and safety data from two single-arm phase II studies …
[HTML][HTML] Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With
ALK-Positive Non–Small-Cell Lung Cancer - PMC Back to Top Skip to main content NIH NLM …
ALK-Positive Non–Small-Cell Lung Cancer - PMC Back to Top Skip to main content NIH NLM …
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer
SM Gadgeel, AT Shaw, R Govindan… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Alectinib has shown activity in the CNS in phase I and II studies. To further evaluate
this activity, we pooled efficacy and safety data from two single-arm phase II studies …
this activity, we pooled efficacy and safety data from two single-arm phase II studies …